|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
 
|
2/2025
vol. 100 abstract:
Review paper
Reviving hope – the journey of diagnosing and treating Guillain-Barré syndrome
Anna Oleszczuk
1
,
Julia Kozieł
1
,
Szymon Kosmala
1
,
Noemi Kufrejska
1
,
Paweł Hawranik
1
,
Katarzyna Jurkiewicz
1
,
Marcelina Kurek
1
,
Magdalena Chrościńska-Krawczyk
2
Pediatr Pol 2025; 100 (2): 166-172
Online publish date: 2025/06/06
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The Guillain-Barré syndrome (GBS) is a rare but serious neurological condition that continues to pose diagnostic and therapeutic challenges, particularly in paediatrics. Although most paediatric patients achieve full recovery, some experience persisting complications such as chronic pain, paraesthesia, or reduced physical capacity. This study provides a comprehensive review of GBS, addressing its epidemiology, pathogenesis, clinical symptoms, as well as diagnostic and therapeutic tools. An integrated treatment approach, encompassing both causal and symptomatic therapies, plays a pivotal role in the recovery process. In recent years, novel biologic therapies, such as eculizumab and efgartigimod, have emerged as promising treatment options. However, further research is required, especially within the context of the paediatric population.
keywords:
autoimmune diseases, Guillain-Barré syndrome, peripheral nervous system diseases |
POLSKI
